Co-prescription of Aerochamber ® spacer with non-extrafine beclometasone diproprionate (non-EF BDP) is common but unlicensed. We report a comparison of inhaled corticosteroid (ICS)-related adverse ...
SEATTLE, Nov. 12, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global asthma spacer market is estimated to be valued at US$ 1,637.5 million in 2021 and is expected to exhibit a ...
New York, July 04, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Asthma Spacers Market Forecast to 2028 - COVID-19 Impact and Global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results